X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6753) 6753
Patent (471) 471
Conference Proceeding (295) 295
Publication (278) 278
Paper (133) 133
Book Chapter (118) 118
Book / eBook (39) 39
Dissertation (35) 35
Report (17) 17
Technical Report (5) 5
Book Review (1) 1
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1675) 1675
male (1168) 1168
female (1121) 1121
index medicus (897) 897
animals (785) 785
middle aged (784) 784
aged (624) 624
adult (572) 572
mice (375) 375
oncology (339) 339
surgery (311) 311
chemistry (275) 275
analysis (265) 265
biochemistry & molecular biology (264) 264
cancer (263) 263
rats (229) 229
medicine & public health (226) 226
chemistry, multidisciplinary (223) 223
metallurgy (219) 219
expression (218) 218
dermatology (202) 202
treatment outcome (199) 199
japan (196) 196
physics (196) 196
aged, 80 and over (193) 193
research (193) 193
physics, particles & fields (182) 182
pharmacology & pharmacy (168) 168
experiment (164) 164
prognosis (161) 161
immunology (152) 152
high energy physics (141) 141
retrospective studies (135) 135
particle physics (134) 134
physics, applied (133) 133
time factors (132) 132
cell biology (131) 131
care and treatment (130) 130
adolescent (128) 128
immunohistochemistry (128) 128
molecular sequence data (126) 126
high energy physics - experiment (124) 124
physics - high energy physics - experiment (123) 123
performing operations (121) 121
transporting (121) 121
chemotherapy (117) 117
cells (115) 115
proteins (113) 113
materials science, multidisciplinary (112) 112
organic chemistry (108) 108
biotechnology & applied microbiology (107) 107
activation (106) 106
amino acid sequence (105) 105
surgical oncology (103) 103
gene expression (102) 102
child (100) 100
multidisciplinary sciences (98) 98
gastroenterology & hepatology (97) 97
tumors (97) 97
base sequence (96) 96
breast cancer (96) 96
health aspects (96) 96
cells, cultured (92) 92
cardiac & cardiovascular systems (91) 91
chemistry, physical (90) 90
lep (90) 90
risk factors (90) 90
therapy (89) 89
cell line (87) 87
dogs (87) 87
follow-up studies (87) 87
metastasis (87) 87
gene (86) 86
human necessities (84) 84
clinical neurology (83) 83
food science & technology (83) 83
mutation (83) 83
disease (82) 82
identification (82) 82
phenomenology (82) 82
microbiology (81) 81
protein (81) 81
genetic aspects (80) 80
medicine, general & internal (80) 80
survival rate (80) 80
neoplasm staging (79) 79
kinetics (77) 77
physiological aspects (77) 77
diagnosis (76) 76
esophageal cancer (76) 76
survival (76) 76
medicine (75) 75
mice, inbred c57bl (75) 75
e+e annihilation (74) 74
physics, multidisciplinary (74) 74
research article (73) 73
electricity (72) 72
neurosciences (72) 72
genetics & heredity (71) 71
growth (71) 71
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (18) 18
East Asian (Cheng Yu Tung) - Stacks (12) 12
Robarts - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Mathematical Sciences - Stacks (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7073) 7073
Japanese (543) 543
French (45) 45
Chinese (39) 39
German (27) 27
Portuguese (15) 15
Spanish (4) 4
Korean (2) 2
Czech (1) 1
Danish (1) 1
Polish (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Angewandte Chemie International Edition, ISSN 1433-7851, 07/2012, Volume 51, Issue 27, pp. 6643 - 6647
Regioisomers of self‐assembling molecules resulted in the evolution of distinct 0D and 1D nanostructures, namely nanorings and nanorods (see picture). J‐ and... 
J‐aggregates | H‐aggregates | supramolecular chemistry | nanorings | self‐assembly | H-aggregates | self-assembly | J-aggregates | BACTERIA | DYES | COMPLEXES | DISCOTIC LIQUID-CRYSTALS | CHEMISTRY, MULTIDISCIPLINARY | TRANSPORT | ASSEMBLIES | SUPRAMOLECULAR DENDRIMERS | SYSTEMS | AGGREGATION
Journal Article
Automatica, ISSN 0005-1098, 2006, Volume 42, Issue 1, pp. 93 - 100
A design method of multivariable PID controllers that satisfy the performance index of the standard control problem and linear constraints on the control... 
MIMO | PID control | [formula omitted] control | Frequency domains | Decentralized control | H | control | Mechanical engineering | Standards
Journal Article
FASEB JOURNAL, ISSN 0892-6638, 03/2019, Volume 33, Issue 3, pp. 3392 - 3403
Allergic conjunctivitis (AC) is one of the most common ocular surface diseases in the world. In AC, T helper type 2 (T(h)2) immune responses play central roles... 
eicosanoid | EOSINOPHILS | BIOCHEMISTRY & MOLECULAR BIOLOGY | fish oil | MAST-CELLS | RECEPTOR | CELL BIOLOGY | FISH-OIL SUPPLEMENTATION | MURINE MODEL | RESOLVIN D1 | inflammation | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | HIGH-RISK | BIOLOGY | hay fever | PROSTAGLANDIN D-2 | lipidomics
Journal Article
AUTOMATICA, ISSN 0005-1098, 01/2006, Volume 42, Issue 1, pp. 93 - 100
A design method of multivariable PID controllers that satisfy the performance index of the standard Hoc control problem and linear constraints on the control... 
H-infinity control | decentralized control | ROBUST | PERFORMANCE | frequency domains | MIMO | PID control | AUTOMATION & CONTROL SYSTEMS | ENGINEERING, ELECTRICAL & ELECTRONIC
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article